ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bile Duct Cancer Drugs Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-2A3274
Home | Market Reports | Health| Health Conditions| Cancer
Global Bile Duct Cancer Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Bile Duct Cancer Drugs Market Insights, Forecast to 2030

Code: QYRE-Auto-2A3274
Report
December 2024
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Pfizer Inc
Celgene
Mylan NV
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
TEVA
AbbVie
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi

Bile Duct Cancer Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bile Duct Cancer Drugs Market

Bile Duct Cancer Drugs Market

Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unknown, but few factors that cause bile duct cancer are long-term inflammation in the liver, biliary stones, abnormalities in bile duct such as cysts, infection with liver fluke parasites leading to bile duct leading to cancer, and exposure to harmful chemicals or toxins. Major symptoms associated with bile duct cancer include jaundice, weight loss, loss of appetite, discoloration of urine and stool, abdominal pain, itching, and fever. Some drugs used to treat bile duct cancer include 5-fluorouracil (5-fu), gemcitabine, cisplatin, capecitabine and oxaliplatin.
Market Analysis and Insights: Global Bile Duct Cancer Drugs Market
The global Bile Duct Cancer Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Bile Duct Cancer Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Bile Duct Cancer Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bile Duct Cancer Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bile Duct Cancer Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Bile Duct Cancer Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Bile Duct Cancer Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Bile Duct Cancer Drugs Market Report

Report Metric Details
Report Name Bile Duct Cancer Drugs Market
CAGR 5%
Segment by Type
  • 5-Fluorouracil (5-FU)
  • Gemcitabine
  • Cisplatin
  • Capecitabine
  • Oxaliplatin
  • Others
Segment by Application
  • Hospitals & Clinic
  • Cancer Treatment Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Celgene, Mylan, Eli Lilly, Johnson & Johnson, Accord Healthcare, Roche, Teva, AbbVie, Bristol-Myers Squibb, Pfizer, Intercept Pharmaceuticals, Novartis, Sanofi, Kyowa Hakko Kirin, Delcath Systems, Fresenius Kabi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Bile Duct Cancer Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bile Duct Cancer Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bile Duct Cancer Drugs revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Bile Duct Cancer Drugs Market report?

Ans: The main players in the Bile Duct Cancer Drugs Market are Celgene, Mylan, Eli Lilly, Johnson & Johnson, Accord Healthcare, Roche, Teva, AbbVie, Bristol-Myers Squibb, Pfizer, Intercept Pharmaceuticals, Novartis, Sanofi, Kyowa Hakko Kirin, Delcath Systems, Fresenius Kabi

What are the Application segmentation covered in the Bile Duct Cancer Drugs Market report?

Ans: The Applications covered in the Bile Duct Cancer Drugs Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Bile Duct Cancer Drugs Market report?

Ans: The Types covered in the Bile Duct Cancer Drugs Market report are 5-Fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin, Others

Recommended Reports

Liver and Biliary Diseases

Cancer Drug Markets

Cancer Diagnostics & Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bile Duct Cancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 5-Fluorouracil (5-FU)
1.2.3 Gemcitabine
1.2.4 Cisplatin
1.2.5 Capecitabine
1.2.6 Oxaliplatin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bile Duct Cancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bile Duct Cancer Drugs Market Perspective (2019-2030)
2.2 Global Bile Duct Cancer Drugs Growth Trends by Region
2.2.1 Bile Duct Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bile Duct Cancer Drugs Historic Market Size by Region (2019-2024)
2.2.3 Bile Duct Cancer Drugs Forecasted Market Size by Region (2025-2030)
2.3 Bile Duct Cancer Drugs Market Dynamics
2.3.1 Bile Duct Cancer Drugs Industry Trends
2.3.2 Bile Duct Cancer Drugs Market Drivers
2.3.3 Bile Duct Cancer Drugs Market Challenges
2.3.4 Bile Duct Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bile Duct Cancer Drugs by Players
3.1.1 Global Bile Duct Cancer Drugs Revenue by Players (2019-2024)
3.1.2 Global Bile Duct Cancer Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Bile Duct Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bile Duct Cancer Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Bile Duct Cancer Drugs Market Concentration Ratio
3.4.1 Global Bile Duct Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Drugs Revenue in 2023
3.5 Global Key Players of Bile Duct Cancer Drugs Head office and Area Served
3.6 Global Key Players of Bile Duct Cancer Drugs, Product and Application
3.7 Global Key Players of Bile Duct Cancer Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bile Duct Cancer Drugs Breakdown Data by Type
4.1 Global Bile Duct Cancer Drugs Historic Market Size by Type (2019-2024)
4.2 Global Bile Duct Cancer Drugs Forecasted Market Size by Type (2025-2030)
5 Bile Duct Cancer Drugs Breakdown Data by Application
5.1 Global Bile Duct Cancer Drugs Historic Market Size by Application (2019-2024)
5.2 Global Bile Duct Cancer Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bile Duct Cancer Drugs Market Size (2019-2030)
6.2 North America Bile Duct Cancer Drugs Market Size by Type
6.2.1 North America Bile Duct Cancer Drugs Market Size by Type (2019-2024)
6.2.2 North America Bile Duct Cancer Drugs Market Size by Type (2025-2030)
6.2.3 North America Bile Duct Cancer Drugs Market Share by Type (2019-2030)
6.3 North America Bile Duct Cancer Drugs Market Size by Application
6.3.1 North America Bile Duct Cancer Drugs Market Size by Application (2019-2024)
6.3.2 North America Bile Duct Cancer Drugs Market Size by Application (2025-2030)
6.3.3 North America Bile Duct Cancer Drugs Market Share by Application (2019-2030)
6.4 North America Bile Duct Cancer Drugs Market Size by Country
6.4.1 North America Bile Duct Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Bile Duct Cancer Drugs Market Size by Country (2019-2024)
6.4.3 North America Bile Duct Cancer Drugs Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Bile Duct Cancer Drugs Market Size (2019-2030)
7.2 Europe Bile Duct Cancer Drugs Market Size by Type
7.2.1 Europe Bile Duct Cancer Drugs Market Size by Type (2019-2024)
7.2.2 Europe Bile Duct Cancer Drugs Market Size by Type (2025-2030)
7.2.3 Europe Bile Duct Cancer Drugs Market Share by Type (2019-2030)
7.3 Europe Bile Duct Cancer Drugs Market Size by Application
7.3.1 Europe Bile Duct Cancer Drugs Market Size by Application (2019-2024)
7.3.2 Europe Bile Duct Cancer Drugs Market Size by Application (2025-2030)
7.3.3 Europe Bile Duct Cancer Drugs Market Share by Application (2019-2030)
7.4 Europe Bile Duct Cancer Drugs Market Size by Country
7.4.1 Europe Bile Duct Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Bile Duct Cancer Drugs Market Size by Country (2019-2024)
7.4.3 Europe Bile Duct Cancer Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bile Duct Cancer Drugs Market Size (2019-2030)
8.2 China Bile Duct Cancer Drugs Market Size by Type
8.2.1 China Bile Duct Cancer Drugs Market Size by Type (2019-2024)
8.2.2 China Bile Duct Cancer Drugs Market Size by Type (2025-2030)
8.2.3 China Bile Duct Cancer Drugs Market Share by Type (2019-2030)
8.3 China Bile Duct Cancer Drugs Market Size by Application
8.3.1 China Bile Duct Cancer Drugs Market Size by Application (2019-2024)
8.3.2 China Bile Duct Cancer Drugs Market Size by Application (2025-2030)
8.3.3 China Bile Duct Cancer Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Bile Duct Cancer Drugs Market Size (2019-2030)
9.2 Asia Bile Duct Cancer Drugs Market Size by Type
9.2.1 Asia Bile Duct Cancer Drugs Market Size by Type (2019-2024)
9.2.2 Asia Bile Duct Cancer Drugs Market Size by Type (2025-2030)
9.2.3 Asia Bile Duct Cancer Drugs Market Share by Type (2019-2030)
9.3 Asia Bile Duct Cancer Drugs Market Size by Application
9.3.1 Asia Bile Duct Cancer Drugs Market Size by Application (2019-2024)
9.3.2 Asia Bile Duct Cancer Drugs Market Size by Application (2025-2030)
9.3.3 Asia Bile Duct Cancer Drugs Market Share by Application (2019-2030)
9.4 Asia Bile Duct Cancer Drugs Market Size by Region
9.4.1 Asia Bile Duct Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Bile Duct Cancer Drugs Market Size by Region (2019-2024)
9.4.3 Asia Bile Duct Cancer Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Celgene
11.1.1 Celgene Company Details
11.1.2 Celgene Business Overview
11.1.3 Celgene Bile Duct Cancer Drugs Introduction
11.1.4 Celgene Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.1.5 Celgene Recent Developments
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Bile Duct Cancer Drugs Introduction
11.2.4 Mylan Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.2.5 Mylan Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Bile Duct Cancer Drugs Introduction
11.3.4 Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.3.5 Eli Lilly Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Bile Duct Cancer Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Bile Duct Cancer Drugs Introduction
11.5.4 Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.5.5 Accord Healthcare Recent Developments
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Bile Duct Cancer Drugs Introduction
11.6.4 Roche Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.6.5 Roche Recent Developments
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Bile Duct Cancer Drugs Introduction
11.7.4 Teva Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.7.5 Teva Recent Developments
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Bile Duct Cancer Drugs Introduction
11.8.4 AbbVie Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.8.5 AbbVie Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Bile Duct Cancer Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bile Duct Cancer Drugs Introduction
11.10.4 Pfizer Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.10.5 Pfizer Recent Developments
11.11 Intercept Pharmaceuticals
11.11.1 Intercept Pharmaceuticals Company Details
11.11.2 Intercept Pharmaceuticals Business Overview
11.11.3 Intercept Pharmaceuticals Bile Duct Cancer Drugs Introduction
11.11.4 Intercept Pharmaceuticals Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.11.5 Intercept Pharmaceuticals Recent Developments
11.12 Novartis
11.12.1 Novartis Company Details
11.12.2 Novartis Business Overview
11.12.3 Novartis Bile Duct Cancer Drugs Introduction
11.12.4 Novartis Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.12.5 Novartis Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Bile Duct Cancer Drugs Introduction
11.13.4 Sanofi Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.13.5 Sanofi Recent Developments
11.14 Kyowa Hakko Kirin
11.14.1 Kyowa Hakko Kirin Company Details
11.14.2 Kyowa Hakko Kirin Business Overview
11.14.3 Kyowa Hakko Kirin Bile Duct Cancer Drugs Introduction
11.14.4 Kyowa Hakko Kirin Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.14.5 Kyowa Hakko Kirin Recent Developments
11.15 Delcath Systems
11.15.1 Delcath Systems Company Details
11.15.2 Delcath Systems Business Overview
11.15.3 Delcath Systems Bile Duct Cancer Drugs Introduction
11.15.4 Delcath Systems Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.15.5 Delcath Systems Recent Developments
11.16 Fresenius Kabi
11.16.1 Fresenius Kabi Company Details
11.16.2 Fresenius Kabi Business Overview
11.16.3 Fresenius Kabi Bile Duct Cancer Drugs Introduction
11.16.4 Fresenius Kabi Revenue in Bile Duct Cancer Drugs Business (2019-2024)
11.16.5 Fresenius Kabi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bristol–Myers Squibb
Pfizer Inc
Celgene
Mylan NV
Eli Lilly
Johnson & Johnson
Accord Healthcare
Roche
TEVA
AbbVie
Intercept Pharmaceuticals
Novartis
Sanofi
Kyowa Hakko Kirin
Delcath Systems
Fresenius Kabi
List of Tables
    Table 1. Global Bile Duct Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of 5-Fluorouracil (5-FU)
    Table 3. Key Players of Gemcitabine
    Table 4. Key Players of Cisplatin
    Table 5. Key Players of Capecitabine
    Table 6. Key Players of Oxaliplatin
    Table 7. Key Players of Others
    Table 8. Global Bile Duct Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Bile Duct Cancer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Bile Duct Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Bile Duct Cancer Drugs Market Share by Region (2019-2024)
    Table 12. Global Bile Duct Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Bile Duct Cancer Drugs Market Share by Region (2025-2030)
    Table 14. Bile Duct Cancer Drugs Market Trends
    Table 15. Bile Duct Cancer Drugs Market Drivers
    Table 16. Bile Duct Cancer Drugs Market Challenges
    Table 17. Bile Duct Cancer Drugs Market Restraints
    Table 18. Global Bile Duct Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Bile Duct Cancer Drugs Revenue Share by Players (2019-2024)
    Table 20. Global Top Bile Duct Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer Drugs as of 2023)
    Table 21. Global Bile Duct Cancer Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Bile Duct Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Bile Duct Cancer Drugs, Headquarters and Area Served
    Table 24. Global Key Players of Bile Duct Cancer Drugs, Product and Application
    Table 25. Global Key Players of Bile Duct Cancer Drugs, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2019-2024)
    Table 29. Global Bile Duct Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Bile Duct Cancer Drugs Revenue Market Share by Type (2025-2030)
    Table 31. Global Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Bile Duct Cancer Drugs Revenue Share by Application (2019-2024)
    Table 33. Global Bile Duct Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Bile Duct Cancer Drugs Revenue Share by Application (2025-2030)
    Table 35. North America Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Bile Duct Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Bile Duct Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Bile Duct Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Bile Duct Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Bile Duct Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Bile Duct Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Bile Duct Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Bile Duct Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Bile Duct Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Bile Duct Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Bile Duct Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Bile Duct Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Bile Duct Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Bile Duct Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Bile Duct Cancer Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Bile Duct Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Bile Duct Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Celgene Company Details
    Table 68. Celgene Business Overview
    Table 69. Celgene Bile Duct Cancer Drugs Product
    Table 70. Celgene Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 71. Celgene Recent Developments
    Table 72. Mylan Company Details
    Table 73. Mylan Business Overview
    Table 74. Mylan Bile Duct Cancer Drugs Product
    Table 75. Mylan Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 76. Mylan Recent Developments
    Table 77. Eli Lilly Company Details
    Table 78. Eli Lilly Business Overview
    Table 79. Eli Lilly Bile Duct Cancer Drugs Product
    Table 80. Eli Lilly Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 81. Eli Lilly Recent Developments
    Table 82. Johnson & Johnson Company Details
    Table 83. Johnson & Johnson Business Overview
    Table 84. Johnson & Johnson Bile Duct Cancer Drugs Product
    Table 85. Johnson & Johnson Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 86. Johnson & Johnson Recent Developments
    Table 87. Accord Healthcare Company Details
    Table 88. Accord Healthcare Business Overview
    Table 89. Accord Healthcare Bile Duct Cancer Drugs Product
    Table 90. Accord Healthcare Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 91. Accord Healthcare Recent Developments
    Table 92. Roche Company Details
    Table 93. Roche Business Overview
    Table 94. Roche Bile Duct Cancer Drugs Product
    Table 95. Roche Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 96. Roche Recent Developments
    Table 97. Teva Company Details
    Table 98. Teva Business Overview
    Table 99. Teva Bile Duct Cancer Drugs Product
    Table 100. Teva Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 101. Teva Recent Developments
    Table 102. AbbVie Company Details
    Table 103. AbbVie Business Overview
    Table 104. AbbVie Bile Duct Cancer Drugs Product
    Table 105. AbbVie Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 106. AbbVie Recent Developments
    Table 107. Bristol-Myers Squibb Company Details
    Table 108. Bristol-Myers Squibb Business Overview
    Table 109. Bristol-Myers Squibb Bile Duct Cancer Drugs Product
    Table 110. Bristol-Myers Squibb Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 111. Bristol-Myers Squibb Recent Developments
    Table 112. Pfizer Company Details
    Table 113. Pfizer Business Overview
    Table 114. Pfizer Bile Duct Cancer Drugs Product
    Table 115. Pfizer Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 116. Pfizer Recent Developments
    Table 117. Intercept Pharmaceuticals Company Details
    Table 118. Intercept Pharmaceuticals Business Overview
    Table 119. Intercept Pharmaceuticals Bile Duct Cancer Drugs Product
    Table 120. Intercept Pharmaceuticals Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 121. Intercept Pharmaceuticals Recent Developments
    Table 122. Novartis Company Details
    Table 123. Novartis Business Overview
    Table 124. Novartis Bile Duct Cancer Drugs Product
    Table 125. Novartis Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 126. Novartis Recent Developments
    Table 127. Sanofi Company Details
    Table 128. Sanofi Business Overview
    Table 129. Sanofi Bile Duct Cancer Drugs Product
    Table 130. Sanofi Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 131. Sanofi Recent Developments
    Table 132. Kyowa Hakko Kirin Company Details
    Table 133. Kyowa Hakko Kirin Business Overview
    Table 134. Kyowa Hakko Kirin Bile Duct Cancer Drugs Product
    Table 135. Kyowa Hakko Kirin Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 136. Kyowa Hakko Kirin Recent Developments
    Table 137. Delcath Systems Company Details
    Table 138. Delcath Systems Business Overview
    Table 139. Delcath Systems Bile Duct Cancer Drugs Product
    Table 140. Delcath Systems Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 141. Delcath Systems Recent Developments
    Table 142. Fresenius Kabi Company Details
    Table 143. Fresenius Kabi Business Overview
    Table 144. Fresenius Kabi Bile Duct Cancer Drugs Product
    Table 145. Fresenius Kabi Revenue in Bile Duct Cancer Drugs Business (2019-2024) & (US$ Million)
    Table 146. Fresenius Kabi Recent Developments
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Bile Duct Cancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Bile Duct Cancer Drugs Market Share by Type: 2023 VS 2030
    Figure 3. 5-Fluorouracil (5-FU) Features
    Figure 4. Gemcitabine Features
    Figure 5. Cisplatin Features
    Figure 6. Capecitabine Features
    Figure 7. Oxaliplatin Features
    Figure 8. Others Features
    Figure 9. Global Bile Duct Cancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Bile Duct Cancer Drugs Market Share by Application: 2023 VS 2030
    Figure 11. Hospitals & Clinic Case Studies
    Figure 12. Cancer Treatment Centers Case Studies
    Figure 13. Others Case Studies
    Figure 14. Bile Duct Cancer Drugs Report Years Considered
    Figure 15. Global Bile Duct Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Bile Duct Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Bile Duct Cancer Drugs Market Share by Region: 2023 VS 2030
    Figure 18. Global Bile Duct Cancer Drugs Market Share by Players in 2023
    Figure 19. Global Top Bile Duct Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer Drugs as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Bile Duct Cancer Drugs Revenue in 2023
    Figure 21. North America Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Bile Duct Cancer Drugs Market Share by Type (2019-2030)
    Figure 23. North America Bile Duct Cancer Drugs Market Share by Application (2019-2030)
    Figure 24. North America Bile Duct Cancer Drugs Market Share by Country (2019-2030)
    Figure 25. United States Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Bile Duct Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Bile Duct Cancer Drugs Market Share by Type (2019-2030)
    Figure 29. Europe Bile Duct Cancer Drugs Market Share by Application (2019-2030)
    Figure 30. Europe Bile Duct Cancer Drugs Market Share by Country (2019-2030)
    Figure 31. Germany Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Bile Duct Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Bile Duct Cancer Drugs Market Share by Type (2019-2030)
    Figure 39. China Bile Duct Cancer Drugs Market Share by Application (2019-2030)
    Figure 40. Asia Bile Duct Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Bile Duct Cancer Drugs Market Share by Type (2019-2030)
    Figure 42. Asia Bile Duct Cancer Drugs Market Share by Application (2019-2030)
    Figure 43. Asia Bile Duct Cancer Drugs Market Share by Region (2019-2030)
    Figure 44. Japan Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Bile Duct Cancer Drugs Market Share by Country (2019-2030)
    Figure 54. Brazil Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Bile Duct Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Celgene Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 61. Mylan Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 62. Eli Lilly Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 64. Accord Healthcare Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 65. Roche Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 66. Teva Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 67. AbbVie Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 69. Pfizer Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 70. Intercept Pharmaceuticals Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 71. Novartis Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 72. Sanofi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 73. Kyowa Hakko Kirin Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 74. Delcath Systems Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 75. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Drugs Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Bile Duct Cancer Drug Market Research Report 2024
Global Pancreatic and Bile Duct Cancer Drug Market Insights Forecast to 2030
Global Gallbladder Cancer Treatment Market Research Report 2024
Biliary Drainage Tube Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liver Cancer Therapeutics Market Insights Forecast to 2030
Medical Biliary Stent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bile Acid Market Insights Forecast to 2030
Global Liver Cancer Treatment Drug Market Research Report 2025
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bile Duct Cancer Therapeutics Market Insights Forecast to 2030
Global Biliary Tumor Market Insights Forecast to 2030
Bile Duct Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cholangiocarcinoma Pipeline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gallbladder Cancer Therapeutics Market Insights Forecast to 2030
Biliary Tract Cancers BTCs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Choledocholithiasis Treatment Market Research Report 2024
Global Bile Duct Drainage Tube Market Research Report 2025
Global Esophageal Cancer Drugs Market Insights Forecast to 2030
Global Jaundice Therapy Instrument Market Research Report 2024
Global Biliary Tract Disorder Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions